000 | 01218 a2200325 4500 | ||
---|---|---|---|
005 | 20250515172925.0 | ||
264 | 0 | _c20091102 | |
008 | 200911s 0 0 spa d | ||
022 | _a1130-6343 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPérez Rodrigo, I | |
245 | 0 | 0 |
_a[Effectiveness and safety of erlotinib in 2 patients with carcinoma of the cervix]. _h[electronic resource] |
260 |
_bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria _c |
||
300 |
_a96-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aErlotinib Hydrochloride |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
700 | 1 | _aAlbornoz López, R | |
700 | 1 | _aSoto Rojas, M | |
700 | 1 | _aFernández García, I | |
700 | 1 | _aTorres Degayón, V | |
773 | 0 |
_tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria _gvol. 33 _gno. 2 _gp. 96-9 |
|
999 |
_c18905835 _d18905835 |